Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a phone app ease PTSD? small study tests BounceBack now in primary care

NCT ID NCT05374408

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested a mobile app called BounceBack Now, designed to help people manage trauma-related mental health issues like PTSD, depression, and anxiety. Researchers worked with 29 adults in primary care, including many from underserved groups, to see if the app was easy to use and acceptable. The goal was to develop better ways to bring this digital tool into routine care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
BounceBack Now mobile app
What this could lead to
If successful, this could provide a simple, self-help tool for managing PTSD symptoms in primary care, especially for underserved groups.
What could go wrong
This is a very small, early feasibility study with only 29 participants. It focuses on whether the app is usable, not on whether it actually improves PTSD symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

29 people

The number who actually took part.

Started

Aug 2022

Finished

Mar 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants with a trauma related disorder and behavioral health providers (BHPs) which are Clinical staff, providers and administration

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Behavioral Health Providers: • 19 years and older Participants: * 19 years and older * Newly referred to a behavioral health provider at the Fontanelle or Midtown Clinic * Own a smart phone Exclusion Criteria Behavioral Health Providers: • 18 years and younger Participants: * 18 years and younger * Referred to a behavioral health provider in the past year * Does not own a smart phone * Score 2 points or lower on the Adverse Childhood Experience screening * High suicidality based on a clinical assessment by the behavioral health provider * Having neurocognitive conditions either assessed by a primary care provider or diagnostic code for neurocognitive condition found in the patient note or Electronic Health Record (EHR)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post-traumatic stress disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Nebraska Medical Center-Fontenelle Clinic

    Omaha, Nebraska, 68104, United States

  • Nebraska Medical Center-Midtown Clinic

    Omaha, Nebraska, 68131, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.